Related Experiment Video
Updated: Aug 5, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Methodologic Standards for Follow-Up Extension in Cardiovascular Trials: A Scientific Statement From the American
Circulation
|August 3, 2026
Summary
Extension trials are crucial for assessing long-term cardiovascular intervention safety and efficacy. This statement provides best practices for designing, analyzing, and reporting these vital studies to improve clinical decision-making.
Area of Science:
- Cardiovascular medicine
- Clinical trial methodology
Background:
- Primary randomized trials offer short-term data on cardiovascular interventions.
- Long-term outcomes and delayed effects are critical for clinical decisions but often unaddressed.
- Current methodological standards for extension trials are inconsistent.
Purpose of the Study:
- To establish best practices for cardiovascular trial extension studies.
- To guide consistent design, analysis, and reporting of extension trials.
- To improve the understanding of long-term cardiovascular intervention safety and efficacy.
Main Methods:
- Review of existing literature and methodologies for clinical trial extensions.
- Development of recommendations for outcome selection, follow-up duration, and completeness.
- Guidance on appropriate analytic strategies for evolving treatment effects.
- Discussion of practical considerations for participant retention and data management.
Main Results:
- Defined best practices for selecting outcomes in extension trials.
- Provided recommendations for optimal follow-up duration and ensuring data completeness.
- Outlined suitable analytic strategies for analyzing long-term and evolving treatment effects.
- Addressed practical challenges including participant retention, reconsent, and data continuity.
Conclusions:
- Standardized methodological approaches are needed for cardiovascular trial extensions.
- Implementing these best practices will enhance the quality and reliability of long-term cardiovascular intervention data.
- Improved extension trial conduct will better inform clinical decision-making regarding cardiovascular treatments.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...